ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $341,740 | -32.2% | 50,930 | -10.8% | 0.00% | -33.3% |
| Q1 2023 | $504,317 | -18.4% | 57,114 | -29.4% | 0.00% | -25.0% |
| Q4 2022 | $617,794 | -25.1% | 80,863 | -30.2% | 0.00% | -42.9% |
| Q3 2022 | $825,000 | +36.6% | 115,826 | +684.0% | 0.01% | +75.0% |
| Q2 2021 | $604,000 | +45.2% | 14,773 | +42.9% | 0.00% | +33.3% |
| Q1 2021 | $416,000 | -82.7% | 10,338 | -74.5% | 0.00% | -85.7% |
| Q4 2020 | $2,399,000 | +19.0% | 40,565 | -2.2% | 0.02% | 0.0% |
| Q3 2020 | $2,016,000 | +62.2% | 41,462 | +61.3% | 0.02% | +61.5% |
| Q2 2020 | $1,243,000 | – | 25,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |